Cornercap Investment Counsel Inc Sage Therapeutics, Inc. Call Options Transaction History
Cornercap Investment Counsel Inc
- $637 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SAGE
# of Institutions
221Shares Held
52.7MCall Options Held
207KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA5.75MShares$62.9 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$60 Million1.65% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$53.5 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.75MShares$52 Million0.02% of portfolio
-
State Street Corp Boston, MA4.49MShares$49.2 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $650M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...